A child with influenza A (H1N1)-associated myocarditis rescued by extracorporeal membrane oxygenation

Takeshi Oda1, Hiroshi Yasunaga, Yoshimitsu Tsutsumi

  • 1Department of Cardiovascular Surgery, St. Mary's Hospital, 422 Tsubukuhon-machi, Kurume, Fukuoka, 830-8543, Japan. oda@st-mary-med.or.jp

Insights

A pediatric H1N1 pneumonia case required extracorporeal membrane oxygenation (ECMO). Switching from veno-venous to veno-arterial ECMO successfully managed cardiac arrest and improved outcomes, despite a spinal infarction complication.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Cardiovascular medicine

Background:

  • A 6-year-old boy presented with influenza A, progressing to H1N1 pneumonia unresponsive to initial treatment.
  • The patient developed severe hypoxia and hypercapnia, necessitating mechanical ventilation.

Observation:

  • Veno-venous extracorporeal membrane oxygenation (ECMO) was initiated for respiratory support.
  • An electrical storm of ventricular fibrillation occurred, likely due to influenza myocarditis, refractory to standard treatments.
  • Conversion to veno-arterial ECMO was performed during cardiopulmonary resuscitation.

Findings:

  • Veno-arterial ECMO successfully terminated the electrical storm and improved cardiac output.
  • The patient was supported with veno-arterial ECMO for 107 hours, followed by veno-venous ECMO.
  • Successful weaning from mechanical ventilation was achieved on day 9, with discharge on day 86.

Implications:

  • This case highlights the critical role of transitioning ECMO modes in managing complex pediatric respiratory and cardiac failure.
  • Prompt recognition and intervention with advanced circulatory support are vital for survival in severe H1N1 pneumonia with myocarditis.
  • Spinal infarction emerged as a significant complication, warranting further investigation and preventative strategies.

Related Concept Videos

Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...